High-intensity focused ultrasound for the treatment of localized prostate cancer: 5-Year experience

Urology

Volumn 63, Issue 2, 2004, Pages 297-300

  Blana, Andreas ^a   Walter, Bernhard ^a   Rogenhofer, Sebastian ^a   Wieland, Wolf F ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ANAMNESIS; ANUS FISTULA; ARTICLE; CANCER LOCALIZATION; CONTROLLED STUDY; DEVICE; FOLLOW UP; HEMICOLECTOMY; HIGH INTENSITY FOCUSED ULTRASOUND; HUMAN; HUMAN TISSUE; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MORBIDITY; PENIS ERECTION; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CARCINOMA; QUALITY OF LIFE; RECTOURETHRAL FISTULA; RECTUM FISTULA; SCORING SYSTEM; STRESS INCONTINENCE; TREATMENT OUTCOME; TUMOR BIOPSY; URETHRA FISTULA; URETHRA STENOSIS; URETHRA SURGERY; VALIDATION PROCESS;

EID: 1242319244     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.urology.2003.09.020     Document Type: Article

References (21)

1. Landis S.H., Murray T., Bolden S., et al. Cancer statistics, 1999. CA Cancer J Clin. 49:1999;8-31.
2. Walsh P.C., Partin A.W., Epstein J.I. Cancer control and quality of life following anatomical radical retropubic prostatectomy results at 10 years . J Urol. 152:1994;1831-1836.
3. Augustin H., Hammerer P., Graefen M., et al. Intraoperative and perioperative morbidity of contemporary radical retropubic prostatectomy in a consecutive series of 1243 patients results of a single center between 1999 and 2002 . Eur Urol. 43:2003;113-118.
4. Beerlage H.P., Thüroff S., Madersbacher S., et al. Current status of minimally invasive treatment options for localized prostate carcinoma. Eur Urol. 37:2000;2-13.
5. Zefelsky M.J., Wallner K.E., Ling C.C., et al. Comparison of the 5-year outcome and morbidity of three-dimensional conformal radiotherapy versus transperineal permanent iodine-125 implantation for early stage prostatic cancer. J Clin Oncol. 17:1999;517-522.
6. Radge H., Blasko J.C., Grimm P.D., et al. Brachytherapy for clinically localized prostate cancer results at 7- and 8-year follow-up . Semin Surg Oncol. 13:1997;438-443.
7. Schmidt J.D., Doyle J., Larison S. Prostate cryoablation update 1998 . CA Cancer J Clin. 48:1998;239-253.
8. Lerner S.E., Blute M.L., Zinke H. Critical evaluation of salvage surgery for radio-recurrent/resistant prostate cancer. J Urol. 154:1995;1103-1109.
9. Huber P., Debus J., Jenne J., et al. Therapeutic ultrasound in tumor therapy principles, applications and new developments . Radiologe. 36:1996;64-71.
10. Chapelon J.Y., Margonari J., Vernier F., et al. In vivo effects of high-intensity ultrasound on prostatic adenocarcinoma Dunning R3327. Cancer Res. 52:1992;6353-6357.
11. Madersbacher S., Kratzik C., Susani M., et al. Tissue ablation in benign prostatic hyperplasia with high intensity focused ultrasound. J Urol. 152:1994;1956-1960.
12. Gelet A., Chapelon J.Y., Bouvier R., et al. Treatment of prostate cancer with transrectal focused ultrasound early clinical experience . Eur Urol. 29:1996;174-183.
13. Beerlage H.P., Thüroff S., Debruyne F.M.J., et al. Transrectal high-intensity focused ultrasound using the Ablatherm device in the treatment of localized prostate carcinoma. Urology. 54:1999;273-277.
14. Beerlage H.P., van Leenders G.J.L.H., Osterhof G.O.N., et al. High-intensity focused ultrasound (HIFU) followed after one to two weeks by radical retropubic prostatectomy results of a prospective study . Prostate. 39:1999;41-46.
15. Gelet A., Chapelon J.Y., Bouvier R., et al. Local control of prostate cancer by transrectal high intensity focused ultrasound therapy preliminary results . J Urol. 161:1999;156-162.
16. Chaussy C.G., Thüroff S. High-intensity focused ultrasound in localized prostate cancer. J Endourol. 14:2000;293-299.
17. Gelet A., Chapelon J.Y., Bouvier R., et al. Transrectal high-intensity focused ultrasound minimally invasive therapy of localized prostate cancer . J Endourol. 14:2000;519-528.
18. Uchida T., Sanghvi N.T., Gardner T.A., et al. Transrectal high-intensity focused ultrasound for treatment of patients with stage T1b-2N0M0 localized prostate cancer a preliminary report . Urology. 59:2002;394-399.
19. Consensus statement guidelines for PSA following radiation therapy . Int J Radiat. 37:1997;1035-1041.
20. Critz F.A. A standard definition of disease freedom is needed for prostate cancer undetectable prostate specific antigen compared with the American Society for Therapeutic Radiology and Oncology consensus definition . J Urol. 167:2002;1310-1313.
21. Amling C.L., Bergstrahl E.J., Blute M.L., et al. Defining prostate specific antigen progression after radical prostatectomy what is the most appropriate cut point? J Urol. 165:2001;1146-1151.